01 1Raks Pharma
01 1SILDENAFIL CITRATE USP
01 1India
01 1Active
01 1Complete
GDUFA
DMF Review : Complete
Rev. Date : 2017-08-04
Pay. Date : 2017-07-07
DMF Number : 23509
Submission : 2010-02-02
Status : Active
Type : II
20
Raks Pharma Pvt Ltd, based in India, is a pharmaceutical company that stands out with its certifications from FDA and WHO-GMP.
One of their notable products is SILDENAFIL CITRATE USP, with a corresponding US DMF Number 23509.
Remarkably, this DMF maintains an Active status since its submission on February 02, 2010, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of August 04, 2017, and payment made on July 07, 2017, indicating their dedication to facilitating drug approvals, Categorized as Type II
